October 12, 2020 | 4:58 PM
Pennsylvania treasurer leads calls to lower price of remdesivir
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.
Remdesivir, originally intended as a treatment for Ebola, was developed with $70 million in taxpayer funds.